Juan Luis
Muñoz Bellido
Catedrático de Universidad
![Foto de Manuel](/img/nophoto.png)
Manuel
Segovia Hernández
Publications by the researcher in collaboration with Manuel Segovia Hernández (12)
2020
-
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
The Lancet, Vol. 396, Núm. 10250, pp. 535-544
2014
-
Prevalence of plasmid-mediated quinolone resistance determinants in extended-spectrum β-lactamase-producing and -non-producing enterobacteria in Spain
International Journal of Antimicrobial Agents
2009
-
Actividad in vitro de fosfomicina frente a enterobacterias de origen urinario productoras de betalactamasas de espectro extendido
Revista Espanola de Quimioterapia, Vol. 22, Núm. 1, pp. 25-29
2004
-
In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae
International Journal of Antimicrobial Agents, Vol. 24, Núm. 2, pp. 185-187
2003
-
In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum
International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 492-496
2002
-
In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus
International Journal of Antimicrobial Agents, Vol. 20, Núm. 1, pp. 61-64
2001
-
Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones
Journal of Antimicrobial Chemotherapy, Vol. 47, Núm. 2, pp. 157-161
2000
-
Actividad de nuevas quinolonas frente a aislamientos clinicos de Corynebacterium spp
Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 267-270
-
Actividad in vitro de nuevas quinolonas frente a cepas clinicas de Staphylococcus aureus silvestres y con mutaciones caracterizadas e n gyrA, gyrB y grlA
Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 271-275
1999
-
Efflux pump-mediated quinolone resistance in staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 354-356
-
In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 4, pp. 966-968
1998
-
Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance [3]
Antimicrobial Agents and Chemotherapy